>
KASH PATEL JUST SAID ARRESTS ARE COMING, Comey and others that need cuffs
Netanyahu 'Stunned' by Trump Rhetoric Prohibiting Lebanon Strikes
US Delegation Presses Cuba to Transition to Market Economy – Report
Varmint round turns NATO rifles into drone killers
Researchers Turn Car Battery Acid and Plastic Waste into Clean Hydrogen and New Plastic
'Spin-flip' system pushes solar cell energy conversion efficiency past 100%
A Startup Has Been Quietly Pitching Cloned Human Bodies to Transfer Your Brain Into
DEYE 215kWh LiFePO4 + 125,000W Inverter + 200,000W MPPT = Run A Factory Offgrid!!
China's Unitree Unveils Robot With "Human-Like Physique" That Can Outrun Most People
This $200 Black Shaft Air Conditions Your Home For Free Forever -- Why Is It Banned in the U.S.?
Engineers have developed a material capable of self-repairing more than 1,000 times,...
They bypassed the eye entirely.
The Most Dangerous Race on Earth Isn't Nuclear - It's Quantum.

Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.
Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.